Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants

The primary objective of this study is to evaluate the safety and tolerability of single intravenous infusions of E2814 in healthy adult participants.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - E2814

E2814, intravenous infusion.

Drug - E2814-matched placebo

E2814-matched placebo, intravenous infusion.

Additional Information

Official Study Title

A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of Intravenous Infusions of E2814 in Healthy Subjects

Clinical Trial ID

NCT04231513

ParticipAid ID

dNklKe